Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Karen L Dunlap Insider Profile
4 Followers
Karen L Dunlap, Director at NuGen Medical Devices Inc, holds 150.00K shares in NuGen Medical Devices Inc (Ticker: TSE:NGMD). Most recently, Karen L Dunlap Bought C$100,000 shares of NuGen Medical Devices Inc on Sep 13, 2022 for an estimated value of 10.00K.
Karen L Dunlap has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Director
Roles that Karen L Dunlap holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Karen L Dunlap
Karen L Dunlap's Trading History
List of latest transactions for each holding click on a transaction to see Karen L Dunlap's performance on stock
You May Also Like
Karen L Dunlap insider profile FAQ
What is the percentage of profitable transactions made by Karen L Dunlap?
The percentage of profitable transactions made by Karen L Dunlap is ―.
What is the average return per transaction made by Karen L Dunlap?
The average return per transaction made by Karen L Dunlap is ―.
What stocks does Karen L Dunlap hold?
Karen L Dunlap holds: TSE:NGMD stocks.
What was Karen L Dunlap’s latest transaction?
Karen L Dunlap latest transaction was an Informative Buy of C$10.00K.
What was Karen L Dunlap's most profitable transaction?
Karen L Dunlap’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Karen L Dunlap's role in NuGen Medical Devices Inc?
Karen L Dunlap's role in NuGen Medical Devices Inc is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.